Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-02-19
2000-05-16
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514370, 514372, 514411, 548182, 548183, 548184, 548186, 548189, 548213, 548214, 548440, A61K 31425, C07D41706, C07D27704, C07D20982
Patent
active
060638001
ABSTRACT:
The present invention relates to novel organic compounds, to methods for their preparation, to compositions containing them, to their use for treatment of human and animal disorders, to their use for purification of proteins or glycoproteins, and to their use in diagnosis. The invention relates to modulation of the activity of molecules with phospho-tyrosine recognition units, including protein tyrosine phosphatases (PTPases) and proteins with Src-homology-2 domains, in in vitro systems, microorganisms, eukaryotic cells, whole animals and human beings. The novel organic compounds are compounds of formula (I)
REFERENCES:
Bin Ye et al., Tetrahedron, vol. 52, No. 30, (1996) pp. 9963-9970.
Smyth et al., Tetrahedron Letters, vol. 33, No. 29, pp. 4137-4140 (1992).
Abstract of JP 08157461.
Andersen Henrik Sune
Madsen Peter
Moller Niels Peter Hundahl
Novo Nordisk A S
Oswecki Jane C.
Richter Johann
Rozek Carol E.
Zelson Steve T.
LandOfFree
Modulators of molecules with phosphotyrosine recognition units does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of molecules with phosphotyrosine recognition units, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of molecules with phosphotyrosine recognition units will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-259237